In addition, previous studies have shown that ErbB2 can block autophagy initiation by modulation of Beclin 1 in breast cancer and Alzheimer’s disease29,30, and regulate autophagic cell death by modulation of ATG4B expression in retinal pigment epithelium cells35. This evidence concerns the gene BECN1 and breast carcinoma.